Navigation Links
China-Biotics, Inc. Sees No Impact on Its Business From Dairy Products Safety Concerns
Date:9/25/2008

SHANGHAI, China, Sept. 25 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today provided an update on the impact on the Company's business of the dairy products contamination concerns in China.

"We do not foresee any significant impact to our business, as our current sales to the dairy industry are minimal," said Mr. Jinan Song, China-Biotics' Chairman and Chief Executive Officer. "We expect that by 2009, when our new plant is operational, the dairy product contamination issue will have been resolved. The construction of our new manufacturing facility remains on schedule, and we are in discussions with a number of suppliers of bakery, dairy and pharmaceutical products in preparation for the plant's initial operation at the end of this calendar year."

Milk samples from several Chinese dairy companies, including the three largest producers, have been found to be tainted with melamine, an industrial chemical. In a September 17 executive meeting of China's State Council, officiated by Premier Wen Jiabao, the Council elected to take steps to conduct comprehensive testing of dairy products and carry out other industry reforms.

"We believe that the strengthening of product quality and testing standards in the dairy industry will be a positive development for domestic suppliers that operate to high international standards. China-Biotics is engaged in discussions and qualification processes with several large global suppliers of infant formula and dairy products to the China market, and we believe we are well positioned to benefit as more stringent requirements are implemented in the industry," Mr. Song concluded.

About China-Biotics, Inc.

China-Biotics, Inc. ("China-Biotics," "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements. Through its wholly owned subsidiary, Shanghai Shining Biotechnology Co., Ltd., the Company has operations in Shanghai. Its proprietary product portfolio contains live microbial nutritional supplements under the "Shining" brand. Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang. China-Biotics plans to launch 300 Shining brand retail outlets in major cities in China. Currently, China-Biotics is strategically expanding its production capacity of probiotics to meet growing demand in the bulk additive market. For more information, please visit http://www.chn-biotics.com .

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors include, but are not limited to, the Company's ability to market existing and new products, ability to access to capital for expansion, and changes from anticipated levels of sales, future national or regional economic and competitive conditions, changes in relationships with customers, dependence on its flagship product profits and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, please contact:

CCG Investor Relations

Crocker Coulson, President

Tel: +1-646-213-1915 (New York)

Email: crocker.coulson@ccgir.com

Web: http://www.ccgirasia.com


'/>"/>
SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China-Biotics, Inc. Expands Retail Network to 60 Shining Retail Centers
2. Insurance Impacts Laryngeal Cancer Detection
3. HIVs impact in Zimbabwe explored in new research
4. NYU study points to lasting impact of mild hearing loss on neurological processes
5. Limiting Residents Hours Has Little Impact on Patient Mortality
6. Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations
7. PA Health Department Survey Shows Impact of Income, Gender, Other Factors on Health and Access to Health Care
8. IMPACT initiative looks to improve patient participation in clinical trials
9. ER episode impacts viewers health knowledge and behavior
10. Decision-making by residents on-call has miniscule negative impact on patient care
11. ER episode impacts viewers health knowledge and behavior
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... wellness products to enhance people’s everyday lives, recently attended the January ECRM Trade ... , ATP Science is known for its large range of supplements that keep ...
(Date:1/20/2017)... ... ... Michael and Betsy Brauser celebrated 5 years of Betsy’s participation in a ... has been life-saving as she has been on the trial for more than six ... ovarian cancer in 2009. She underwent standard chemotherapy but a year later went to ...
(Date:1/20/2017)... ... 20, 2017 , ... Vitamin Well has launched two new ... have been produced in collaboration with Zlatan Ibrahimovic and have been developed to ... a successful launch in Sweden last year, the next generation sports drinks VW+001 ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “The Angel”: ... the Lord has set out for each of his children. “The Angel” is the ... School of Music in New York City, and impassioned writer. , When asked of ...
(Date:1/20/2017)... ... ... fine examination of how God handles sin, including how to let go of lingering guilt ... over ten long years has been waiting to release this powerful insight about forgiveness that ... serving the Lord for over twenty years, and he has been preaching and teaching the ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... -- James Gilbart , ... 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ...      ... in a supplement to European Oncology & Haematology ... by James Gilbart and Axel ...
(Date:1/19/2017)... , Jan. 19, 2017   Science Exchange , ... to announce that the first five replication studies ... have been published in eLife today. Despite intense ... the first practical evaluation of reproducibility rates that ... studies. Unlike other assessments of reproducibility, the results ...
Breaking Medicine Technology: